Crystal's MCW Coder Hub🧬 ICD-10-CM H35.3220 — Exudative AMD, Left Eye, Stage Unspecified
Last-Resort Code — Specificity Required
ICD-10 CM H35.3220 is technically a valid 7-character billable code, but it should rarely — if ever — appear on a claim. The 7th character
0signals that the stage of the wet AMD was NOT documented in the medical record. Per ICD-10-CM Official Guidelines Section I.B.4, coders must assign the most specific code the documentation supports. Wet AMD stage is always determinable from OCT findings and physician notes — the absence of stage documentation is a clinical documentation deficiency, not an inherent coding limitation.
Non-Billable Parent Codes — Do Not Submit These Either
The Preferred Left-Eye Wet AMD Codes — Use These Instead
Code Stage Use When H35.3221 Active CNV SRF, IRF, hemorrhage, fluid on OCT or FA documented H35.3222 Inactive CNV Macula dry, CNV regressed/quiescent, T&E or PRN protocol H35.3223 Inactive scar Disciform scar, subretinal fibrosis documented H35.3220 Unspecified ⚠️ ONLY if stage genuinely undocumentable + query failed
🔍 Code Description
ICD-10 CM H35.3220 classifies exudative (wet) age-related macular degeneration of the left eye at an unspecified stage — meaning the medical record documents the presence of wet AMD in the left eye but does not contain sufficient clinical detail to assign the correct 7th character stage (active CNV, inactive CNV, or inactive scar).
The “stage unspecified” designation is a coding placeholder — it exists in the ICD-10-CM tabular to accommodate the rare scenario where complete documentation is unavailable. It is not intended for routine use. In real-world retina practice, every wet AMD note contains OCT results that definitively establish stage — which means H35.3220 appearing on a claim almost always reflects a documentation gap that should have been resolved before billing.
🌳 Code Tree / Hierarchy — Left Eye Wet AMD
H35.32 Exudative AMD ❌ Non-billable header
│
└── H35.322 Left Eye ❌ Non-billable header
│
├── H35.3220 Stage UNSPECIFIED ◀ THIS CODE ⚠️ LAST RESORT
├── H35.3221 Active CNV ⚡ Preferred — use when fluid present
├── H35.3222 Inactive CNV ✅ Preferred — use when macula dry
└── H35.3223 Inactive Scar ✅ Preferred — use when scar documented
📊 The 7th Character Decision Tree — Left Eye Wet AMD
Use This Decision Tree Before Reaching for H35.3220
STEP 1: Is left eye wet AMD (exudative) documented?
└── YES → Continue to Step 2
└── NO → Wrong code family — re-evaluate
STEP 2: Does the OCT note say "fluid" / "SRF" / "IRF" /
"subretinal fluid" / "active CNV" / "hemorrhage"?
└── YES → H35.3221 ✅ (Active CNV)
└── NO → Continue to Step 3
STEP 3: Does the note say "dry" / "no fluid" / "quiescent" /
"inactive" / "involuted CNV" / "regressed" / "controlled"?
└── YES → H35.3222 ✅ (Inactive CNV)
└── NO → Continue to Step 4
STEP 4: Does the note say "scar" / "disciform" / "fibrosis" /
"disciform scar" / "subretinal fibrosis"?
└── YES → H35.3223 ✅ (Inactive Scar)
└── NO → Continue to Step 5
STEP 5: Send CDI QUERY to physician:
"The record documents exudative AMD, left eye.
Please specify the current stage:
□ Active CNV (with subretinal/intraretinal fluid)
□ Inactive CNV (fluid resolved, CNV regressed)
□ Inactive scar (disciform scar/fibrosis present)"
└── Response received → Assign specific code ✅
└── No response / clinically not feasible → H35.3220 ⚠️
🚨 Why H35.3220 Is a Payer Red Flag
Payer Rejection Risk — Anti-VEGF Claims Especially Vulnerable
The Lucentis/Genentech billing resource explicitly warns: “Many payers will not accept unspecified codes.” This applies with greatest force to anti-VEGF injection claims, where medical necessity is tied directly to documented CNV activity. If H35.3220 appears as the diagnosis on a claim with 67028-LT and a drug J-code, the payer cannot determine whether:
- The CNV was active (injection clearly indicated)
- The CNV was inactive (injection requires T&E protocol rationale)
- The eye had a scar (injection may not be indicated at all)
This ambiguity triggers either automatic denial or additional documentation requests — both of which delay payment and increase administrative burden. The specific stage codes eliminate this ambiguity entirely.
Payer Scenarios by Protocol
| Claim Type | H35.3220 Risk Level | Notes |
|---|---|---|
| 67028-LT + J-code (injection) | 🔴 HIGH — likely denial | Active CNV must be documented; H35.3220 insufficient for most MACs |
| 92134 (OCT monitoring) | 🟡 MODERATE — may process | Monitoring is justified for any wet AMD; some payers accept unspecified for monitoring |
| 92014 (exam only) | 🟢 LOWER — may process | E&M less stage-dependent; still suboptimal |
| 92235 (FA) | 🟡 MODERATE | FA medical necessity tied to determining stage — unspecified undermines rationale |
📋 When H35.3220 Actually Belongs on a Claim
The Four Legitimate H35.3220 Scenarios — Rare but Real
There are a small number of clinical documentation situations where H35.3220 is genuinely the most appropriate code available:
Scenario A — Referring Provider Note, Incomplete Documentation
A patient transfers care from another retina practice. The only available documentation is a referral note that reads: “Wet AMD, left eye — follow-up with your retina specialist.” No OCT results included. The receiving physician has not yet seen the patient. An initial evaluation visit is being coded before the new physician’s first OCT.
→ H35.3220 is appropriate for the administrative/intake context. Update to specific stage code at first clinical encounter.
Scenario B — Emergency Department Visit, Ophthalmology Not Available
A patient with known wet AMD left eye presents to an ED with a new complaint (fall, syncope, cardiac event). The ED chart documents the wet AMD history but no eye exam or OCT was performed. No ophthalmology consult was obtained. The ED coder needs to capture the AMD as an additional diagnosis.
→ H35.3220 is appropriate — stage cannot be determined without an eye examination or OCT.
Scenario C — Inpatient Admission, Historical AMD, No Ophthalmic Evaluation
A patient is admitted for a systemic condition. The H&P documents “history of wet AMD, left eye, treated with injections.” The admitting physician does not specify stage. No ophthalmology consult is placed. Query sent → no response within coding window.
→ H35.3220 may be appropriate after query attempt — code to the specificity available. Note in the record that a query was sent.
Scenario D — Physician Documents “Wet AMD” With No Additional Detail
An outpatient note documents only “wet AMD, left eye — continue monitoring” with no OCT report, no fluid status, no stage language. CDI query sent → physician responds “I don’t document the stage — just use whatever code you need.”
→ H35.3220 as last resort — document the query attempt and physician’s non-response in the coding workflow.
Scenario D Is Also a Compliance Red Flag
A retina physician routinely failing to document AMD stage in their notes is a clinical documentation compliance issue that should be escalated — not repeatedly coded as H35.3220. A pattern of H35.3220 claims from a single provider may trigger payer audits. Work with your CDI team to implement provider education and note template changes that prompt stage documentation at every wet AMD visit.
💰 HCC Risk Adjustment (CMS-HCC v28)
| Field | Detail |
|---|---|
| CMS-HCC Model Version | v28 (2024-2025 Implementation) |
| HCC Assignment | ❌ Not Mapped |
| HCC Category | N/A |
| RAF Coefficient | 0.000 |
No HCC weight — identical to all H35.32x codes regardless of stage. The documentation deficiency at H35.3220 also means missed opportunities to capture comorbidity documentation that would otherwise be triggered by a specific-stage encounter. A thorough T&E visit that results in H35.3221 or H35.3222 naturally prompts VA documentation, functional status assessment, and comorbidity review — an underdocumented H35.3220 visit often yields a thinner note overall.
🏥 MS-DRG Assignment
MDC 02 — Diseases and Disorders of the Eye (if principal — extremely rare)
| DRG | Title | Est. Relative Weight* |
|---|---|---|
| DRG 124 | Other Disorders of the Eye with MCC | ~0.95-1.15 |
| DRG 125 | Other Disorders of the Eye with CC | ~0.70-0.90 |
| DRG 126 | Other Disorders of the Eye without CC/MCC | ~0.50-0.70 |
*Verify against IPPS FY2025 Final Rule tables.
🔗 Related ICD-10-CM Codes
Left-Eye Wet AMD Complete Family
| Code | Stage | Status |
|---|---|---|
| H35.3220 | Unspecified ← This Code ⚠️ | Last resort |
| H35.3221 | Active CNV ⚡ | Preferred — fluid present |
| H35.3222 | Inactive CNV ✅ | Preferred — macula dry |
| H35.3223 | Inactive Scar ✅ | Preferred — scar documented |
Laterality Equivalents — Same Stage, Other Eye
| Code | Description |
|---|---|
| H35.3210 | Exudative AMD, right eye, stage unspecified |
| H35.3230 | Exudative AMD, bilateral, stage unspecified |
🛠️ CDI Query Template — H35.3220 → Specific Stage
Copy-Paste CDI Query for Wet AMD Stage
When the record documents wet AMD left eye but lacks stage documentation, use this query to resolve H35.3220 to the correct specific code:
CLINICAL DOCUMENTATION IMPROVEMENT QUERY
Date: _
Patient: _ MRN: _
Encounter Date: _ Provider: _
RE: Dry (Nonexudative) AMD — Laterality AND Stage Clarification Required
The medical record documents age-related macular degeneration
(dry/nonexudative type). Accurate ICD-10-CM coding requires
both the affected eye AND the disease stage.
QUESTION 1 — WHICH EYE IS AFFECTED?
□ Right eye only
□ Left eye only
□ Both eyes (bilateral)
□ Cannot be determined
QUESTION 2 — WHAT IS THE CURRENT STAGE?
(Answer separately for each affected eye)
Right Eye Stage:
□ Early dry (medium drusen, no pigment changes)
□ Intermediate (large drusen or pigment changes)
□ Advanced — geographic atrophy, NOT at foveal center
□ Advanced — geographic atrophy AT foveal center (subfoveal)
□ Stage unspecified / cannot be determined
Left Eye Stage:
□ Early dry (medium drusen, no pigment changes)
□ Intermediate (large drusen or pigment changes)
□ Advanced — geographic atrophy, NOT at foveal center
□ Advanced — geographic atrophy AT foveal center (subfoveal)
□ Stage unspecified / cannot be determined
Physician Signature: _ Date: _
NOTE: Without laterality and stage, only the lowest-specificity
ICD-10-CM code is assignable, which may affect claim processing
and quality metric reporting.
💊 Coding Scenarios
Scenario 1 — Transferred Patient, No Prior OCT Records (Outpatient)
Clinical Vignette: A 76-year-old female transfers from out-of-state retina practice. Today is her first visit. She reports receiving “eye injections” for her left eye for the past two years. No prior records received. The new physician performs a comprehensive exam and orders OCT — however, the OCT machine is down today. Impression: “Wet AMD, left eye — history of treatment — will obtain baseline OCT at next visit.”
CPT / HCPCS:
- 92004 — Comprehensive ophthalmological exam, new patient
- No 92134 — OCT not performed today (machine down)
- No 67028 — No injection today pending baseline
ICD-10-CM:
- H35.3220 — Exudative AMD, left eye, stage unspecified (acceptable here — no OCT performed, no prior records, stage genuinely unknown at this visit; update to specific code at next visit when OCT available)
This Is the Legitimate H35.3220 Scenario
Scenario 2 — Inpatient Admission, Wet AMD in H&P, No Eye Consult (Inpatient)
Clinical Vignette: A 79-year-old male admitted for NSTEMI. H&P by admitting cardiologist notes: “Ocular history: wet AMD left eye, on monthly injections, followed by retina specialist.” No ophthalmology consult placed. No OCT available in the inpatient record. CDI query to cardiologist: “Unable to specify — please contact retina specialist.” Stage not available within coding window.
Additional Diagnosis:
- H35.3220 — Exudative AMD, left eye, stage unspecified (appropriate for inpatient additional diagnosis — stage not determinable from available inpatient record; cardiologist appropriately redirected to retina specialist but no consultation obtained)
Document the Query Attempt in Your Coding Workflow
Even when H35.3220 is the correct code given the circumstances, always document in your coding workflow that a CDI query was attempted and the outcome. This protects the facility in the event of an audit and demonstrates coding compliance effort.
Scenario 3 — Lazy Documentation Pattern — CDI Escalation Needed (Outpatient)
Clinical Vignette: A coder reviews 15 encounters from the same retina physician. Every wet AMD note reads: “Wet AMD — continue monitoring — OCT obtained.” The OCT reports are scanned but not referenced in the physician’s assessment. No fluid status, no stage language, no injection rationale. H35.3220 has been assigned for all 15 encounters spanning 8 months.
Correct Action:
- Do NOT continue assigning H35.3220 — the OCT reports are in the record and contain stage-determining information
- Read the OCT reports — “no fluid” = H35.3222; “subretinal fluid” = H35.3221; “fibrosis” = H35.3223
- UHDDS and coding guideline principle: coders may reference any part of the medical record — if the OCT report establishes stage even without physician narrative restatement, assign the specific code
- Escalate the documentation pattern to the CDI or compliance team — provider education needed
- Retroactively correct the prior 15 claims if within the correction window — H35.3220 on injection claims may have caused denials already
The OCT Report IS Part of the Medical Record
This is a critical coding compliance point. The physician does not need to repeat “active CNV with subretinal fluid” in their assessment if the attached OCT report clearly documents it. The OCT report is part of the legal medical record and may be used to support code assignment. A coder who has access to OCT results showing active fluid has the documentation needed to assign H35.3221 — assigning H35.3220 when the OCT result is available is under-coding, not appropriate caution.
⚠️ Coding Pitfalls and Tips
| Pitfall or Tip | |
|---|---|
| ❌ | Never default to H35.3220 for convenience or speed — always work through the decision tree before settling on unspecified [web:109] |
| ❌ | Never use H35.3220 when OCT results are available — OCT is in the record; read it and assign the specific stage [web:173] |
| ❌ | Never carry H35.3220 forward across visits — once stage is established at any visit, the specific code applies from that point on |
| ❌ | Never bill H35.3220 with 67028-LT + J-code without checking your MAC’s LCD — many payers auto-deny unspecified wet AMD on injection claims [web:130] |
| ❌ | Never treat H35.3220 as a “safe” fallback — it’s a compliance risk, not a safe harbor |
| ✅ | H35.3220 IS appropriate when stage is genuinely unknown — new patient, no records, no OCT, no exam yet |
| ✅ | H35.3220 IS appropriate as an inpatient additional diagnosis when the treating team doesn’t have access to ophthalmic records and no consult was placed |
| ✅ | Use the CDI query template above before finalizing H35.3220 on any outpatient retina claim |
| ✅ | The OCT report is your best friend — if it’s in the chart, read it; fluid = H35.3221, dry = H35.3222, scar = H35.3223 |
| ✅ | A pattern of H35.3220 from one provider → escalate to CDI/compliance; implement note template changes |
| ✅ | Right-eye equivalent is H35.3210 — same rules apply; see H35.3210 note for additional context and parallel examples |
📚 Sources
1. AAPC. “ICD-10 Code H35.3220 — Exudative AMD, left eye, stage unspecified.” Confirmed 7-character billable code per WHO ICD-10-CM classification. [web:170]
2. Unbound Medicine ICD-10-CM. H35.3220 — Exudative AMD, left eye, stage unspecified; tabular structure and citation. [web:171]
3. CodeMap. H35.322x — Left-eye wet AMD family; H35.3220 stage unspecified confirmed. [web:140]
4. GenHealth.ai. H35.3220 ICD10CM — Left eye stage unspecified; right-eye equivalent H35.3210. [web:172]
5. Retinal Physician. “Coding Q&A: Coding Guidelines for Wet AMD.” 7th character requirement: “Coding to the highest specificity is required, so using an unspecified eye diagnosis code would be inappropriate, as would leaving out the relevant seventh digit.” [web:109]
6. AAPC Knowledge Center / My Ophthalmology Coding Alert. “Use This Guide to Identify the Correct AMD ICD-10-CM Codes.” March 2026. “Coders must rely on explicit provider documentation regarding stage. If the stage is not documented, an unspecified stage code may be used.” — with context that this is a last resort per specificity guidelines. [web:173]
7. Lucentis/Genentech. “LUCENTIS Wet AMD Billing Codes.” H35.3220 listed with explicit warning: “Many payers will not accept unspecified codes. If you use an unspecified code, please check with your payer.” [web:130]
8. Highmark Provider Resources. “Exudative Macular Degeneration Coding & Documentation Resource.” Staging documentation requirements and bilateral unequal-stage coding examples. [web:174]
9. CMS. “Billing and Coding: Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI).” H35.3220 listed as covered diagnosis for 92134 OCT — however, stage-specific codes preferred for injection claims per LCD standards. [web:175]